Emisphere Technologies


Sep 22, 08

NEW STORY
08:50 ET Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment

 
Aug 19, 08

08:50 ET Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development

 
Aug 11, 08

08:50 ET Emisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results

 
Aug 07, 08

08:50 ET Emisphere Technologies, Inc. to Hold Conference Call to Announce 2008 Second Quarter Financial Results

 
Aug 05, 08

08:50 ET Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment

 
Jul 28, 08

08:50 ET Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation

 
Jul 08, 08

08:50 ET Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations

 
Jun 30, 08

08:50 ET Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)

 
Jun 23, 08

08:50 ET Emisphere Announces License Agreement With Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonists for Diabetes

 
May 16, 08

08:50 ET Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript

 
May 07, 08

08:30 ET Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results

 
May 02, 08

08:50 ET Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results

 
Apr 28, 08

16:25 ET Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements

 
Apr 16, 08

08:50 ET Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology

 
Apr 15, 08

08:50 ET Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008

 
Mar 19, 08

08:55 ET Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses

 
Mar 17, 08

16:12 ET Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results

 
Mar 14, 08

16:53 ET Emisphere Technologies, Inc. Announces Conference Call for 2007 Fourth Quarter and Year End Financial Results

 
Feb 11, 08

09:46 ET Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12

 
Feb 07, 08

08:50 ET Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology

 
Feb 04, 08

09:51 ET Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12

 
Jan 31, 08

14:49 ET Emisphere to Host Business Strategy Conference Call on February 7

 
Dec 06, 07

08:50 ET Emisphere Names Adam Friedman Associates IR Agency of Record

 
Nov 06, 07

08:55 ET Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results

 
Oct 31, 07

08:55 ET Emisphere Technologies, Inc. Moves Into New Corporate Headquarters

 
Oct 24, 07

09:01 ET Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology

 
Sep 25, 07

09:00 ET Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation

 
Aug 29, 07

09:00 ET Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer

 
Aug 22, 07

08:55 ET Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel

 
Aug 17, 07

09:16 ET Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering

 
Aug 07, 07

08:55 ET Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results

 
Aug 03, 07

08:40 ET Emisphere Technologies, Inc. to Webcast Quarterly Earnings Call

 
Jun 12, 07

08:40 ET Emisphere Technologies, Inc. Appoints Laura Kragie as Vice President of Clinical Development/Chief Medical Officer

 
May 24, 07

07:00 ET Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis

 
May 04, 07

07:00 ET Emisphere Technologies Announces 2007 First Quarter Financial Results

 
May 02, 07

08:00 ET Emisphere Technologies, Inc. to Hold Conference Call to Discuss First Quarter 2007 Financial Results

 
Apr 18, 07

07:00 ET Emisphere Technologies to Hold Annual Stockholders Meeting on April 20, 2007

 
Apr 10, 07

08:00 ET Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer

 
Mar 29, 07

07:00 ET Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY

 
Mar 20, 07

08:00 ET Emisphere Technologies, Inc. Forms Oral Insulin Scientific Advisory Board

 
Mar 12, 07

17:44 ET Emisphere Announces Addendum to Fourth Quarter and Year Ended 2006 Financial Results

 
Feb 27, 07

07:02 ET Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin

 
07:00 ET Emisphere Technologies, Inc. Announces Fourth Quarter and Year End Financial Results for 2006

 
Feb 22, 07

08:00 ET Emisphere Technologies, Inc. to Hold Teleconference to Discuss Fourth Quarter and Year End Financial Results for 2006

 
Feb 08, 07

12:47 ET Emisphere Technologies Announces Presentation/Webcast at BIO CEO Conference

 
Nov 28, 06

08:00 ET Emisphere Technologies, Inc. Presentation at Lazard Capital Markets Life Sciences Conference to be Webcast

 
Nov 09, 06

08:00 ET Emisphere Technologies Announces 2006 Third Quarter Financial Results

 
Nov 08, 06

08:00 ET Emisphere Reports Additional Clinical Data From Phase 2 Oral Insulin Trial

 
Nov 06, 06

08:00 ET Emisphere Technologies, Inc. to Hold Conference Call to Discuss Third Quarter 2006 Financial Results

 
Nov 03, 06

13:32 ET Emisphere Technologies, Inc. Presentation at Rodman & Renshaw 8th Annual Healthcare Conference to be Webcast

 
Oct 17, 06

08:00 ET Emisphere Technologies Presentation at 2006 Bio Investor Forum to be Webcast

 
Sep 25, 06

08:00 ET Emisphere Technologies Presentation at UBS Global Life Sciences Conference to be Webcast

 
Sep 20, 06

08:00 ET Emisphere Technologies Presentation at Oppenheimer Diabetes Conference to be Webcast

 
Sep 12, 06

08:00 ET Emisphere Technologies Presentation at ThinkEquity Partners Growth Conference to Be Webcast

 
Sep 05, 06

08:00 ET Emisphere's eligen(R) Technology Demonstrates Delivery of Active Recombinant Human Growth Hormone

 
Aug 08, 06

08:00 ET Emisphere Technologies Announces 2006 Second Quarter Financial Results

 
Aug 01, 06

08:00 ET Emisphere Technologies, Inc. to Hold Conference Call to Discuss Second Quarter 2006 Financial Results

 
Jul 18, 06

08:00 ET Emisphere Announces New Multi-Product Research Collaboration Agreement with Roche

 
May 25, 06

08:00 ET Emisphere Reports Completion of Planned Preclinical Safety Studies for Oral Calcitonin Program

 
May 23, 06

13:51 ET Emisphere Technologies to Hold Annual Shareholders Meeting on May 25, 2006

 
May 16, 06

10:22 ET Emisphere Technologies Completes Sale of Common Stock

 
May 10, 06

09:41 ET Emisphere Technologies Announces Pricing of Common Stock Offering

 
May 01, 06

12:35 ET Emisphere Technologies, Inc. to Hold Conference Call to Discuss First Quarter 2006 Financial Results

 
11:30 ET Emisphere to Receive Milestone Payment for eligen(R) Technology to Be Used in New Development Program

 
Apr 26, 06

08:10 ET U.S. Federal District Court in Indianapolis Orders Eli Lilly to Assign Intellectual Property to Emisphere

 
Apr 12, 06

08:30 ET Emisphere Provides Update on Use of the eligen(R) Technology to Enhance Pulmonary Delivery of Proteins, Including Insulin

 
Apr 11, 06

08:30 ET Emisphere Completes Enrollment for Phase II Oral Insulin Clinical Trial

 
Apr 07, 06

17:02 ET Emisphere Technologies Announces Appointment of Director, Filing of Shelf Registration Statement, Appointment of Chief Accounting Officer and Approval of Rights Agreement

 
Mar 31, 06

08:31 ET Emisphere Reports Results of Study Comparing its Oral Heparin Formulation to Traditional Injectable Heparin

 
Mar 14, 06

08:02 ET Emisphere Technologies, Inc. Announces Fourth Quarter and Year End Financial Results for 2005

 
Mar 09, 06

15:27 ET Emisphere Technologies, Inc. to Hold Conference Call to Discuss Fourth Quarter and Year End 2005 Financial Results

 
Mar 08, 06

08:00 ET Emisphere Announces Oral PTH License Agreement

 
Mar 01, 06

14:00 ET Emisphere Technologies Announces Presentation and Webcast at the SG Cowen & Co. Health Care Conference

 
Jan 11, 06

17:36 ET Emisphere Technologies Presentation at the 24th Annual JPMorgan Healthcare Conference to be Webcast

 
Jan 10, 06

10:32 ET Emisphere Technologies Presentation at the 24th Annual JPMorgan Healthcare Conference to be Webcast

 
Dec 13, 05

16:30 ET Emisphere Technologies, Inc. Receives Nasdaq Deficiency Notice and Regains Compliance

 
Dec 12, 05

13:29 ET Emisphere Technologies, Inc. Announces the Presentation of Positive Results from a Clinical Study Conducted by Independent Investigators Using Oral Salmon Calcitonin in Osteoarthritis Patients

 
Nov 10, 05

08:50 ET Emisphere Technologies Provides 2005 Third Quarter Update

 
Nov 07, 05

08:32 ET Emisphere Provides Update on Phase III Oral Heparin Trial Design

 
Nov 03, 05

12:28 ET Emisphere Technologies Presentation at the Rodman and Renshaw Techvest Annual Healthcare Conference to be Webcast

 
08:35 ET Emisphere to Commence Phase II Oral Insulin Clinical Trial

 
Oct 21, 05

14:31 ET Emisphere Technologies Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference to be Webcast

 
Oct 17, 05

16:53 ET Emisphere Technologies, Inc. Receives NASDAQ Letter Addressing Need to Add Director

 
Sep 19, 05

10:38 ET Emisphere Technologies Presentation at the Merriman Curhan Ford & Co. 2nd Annual Investor Summit to Be Webcast

 
Sep 12, 05

11:03 ET Emisphere Technologies Presentation at the ThinkEquity Partners 3rd Annual Growth Conference to be Webcast

 
Sep 01, 05

14:13 ET Emisphere Technologies Presentation at the Oppenheimer Diabetes Conference to be Webcast

 
Jul 20, 05

12:18 ET Emisphere Technologies, Inc. to Hold Conference Call to Discuss Second Quarter 2005 Financial Results

 
May 16, 05

14:58 ET Emisphere Technologies Inc. Presentation at the Bank of America Securities Health Care Conference to Be Webcast

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2008 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.